On February 27, 2017, the shares in Vigmed Holding AB were given observation status with reference to a press release published the same day by Greiner Bio-One GmbH with information regarding a public offer to the shareholders in Vigmed Holding AB. Today, on May 3, 2017, Greiner Bio-One GmbH published a press release with information about the outcome of the public offer.
With reference to the above, Nasdaq Stockholm AB has decided that the observation status for the shares in Vigmed Holding AB (VIG, ISIN code SE0005034576, order book ID 92271) shall be removed with effect as of today, May 3, 2017.
For further information about this exchange notice please contact Caroline Folke or Karin Ydén, telephone + 46 8 405 60 00.